Aldeyra Therapeutics Inc
ALDX5.010USD
+0.110+2.24%
收盘 09/18, 16:00（美东）报价延迟15分钟
300.83M总市值
亏损市盈率 TTM
关于 Aldeyra Therapeutics Inc 公司
Aldeyra Therapeutics, Inc. 是一家生物技术公司，致力于发现用于治疗免疫介导疾病的疗法。该公司的候选产品包括活性醛 (RASP) 调节剂 ADX-629、ADX-246、ADX-248 和用于治疗全身和视网膜免疫介导疾病的化学相关分子。其商业化前候选产品是 reproxalap，一种用于治疗干眼症和过敏性结膜炎的 RASP 调节剂，以及 ADX-2191，一种用于治疗增生性玻璃体视网膜病变和视网膜色素变性的新型玻璃体内甲氨蝶呤制剂。其 ADX-629 是一种口服 RASP 调节剂，目前正在临床开发中，用于治疗特应性皮炎、特发性肾病综合征、中度酒精相关性肝炎、慢性咳嗽和 Sjogren-Larsson 综合征。其临床前 RASP 平台包括正在开发用于治疗代谢、视网膜疾病和全身炎症疾病的 ADX-246 和 ADX-248。
公司简介
公司代码ALDX
公司名称Aldeyra Therapeutics Inc
上市日期May 02, 2014
CEODr. Todd C. Brady, M.D., Ph.D.
员工数量9
证券类型Ordinary Share
年结日May 02
公司地址131 Hartwell Avenue
城市LEXINGTON
上市交易所NASDAQ Capital Market Consolidated
国家United States of America
邮编02421
电话17817614904
网址https://www.aldeyra.com/
公司代码ALDX
上市日期May 02, 2014
CEODr. Todd C. Brady, M.D., Ph.D.
公司高管
名称
名称/职务
职务
持股
持股变动
Dr. Todd C. Brady, M.D., Ph.D.
Dr. Todd C. Brady, M.D., Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
1.42M
+23.16%
Dr. Richard H. Douglas, Ph.D.
Dr. Richard H. Douglas, Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
125.00K
--
Mr. Martin J. Joyce
Mr. Martin J. Joyce
Independent Director
Independent Director
23.97K
--
Dr. Gary M. Phillips, M.D.
Dr. Gary M. Phillips, M.D.
Independent Director
Independent Director
14.81K
--
Dr. Neal S. Walker
Dr. Neal S. Walker
Independent Director
Independent Director
--
--
Dr. Stephen G. Machatha, Ph.D.
Dr. Stephen G. Machatha, Ph.D.
Chief Development Officer
Chief Development Officer
--
--
Dr. Ben R. Bronstein, M.D.
Dr. Ben R. Bronstein, M.D.
Independent Director
Independent Director
--
--
Ms. Nancy B. Miller-Rich
Ms. Nancy B. Miller-Rich
Independent Director
Independent Director
--
--
Mr. William (Chip) Clark
Mr. William (Chip) Clark
Independent Director
Independent Director
--
--
Mr. Michael (Mike) Alfieri
Mr. Michael (Mike) Alfieri
Principal Financial Officer and Principal Accounting Officer
Principal Financial Officer and Principal Accounting Officer
--
--
名称
名称/职务
职务
持股
持股变动
Dr. Todd C. Brady, M.D., Ph.D.
Dr. Todd C. Brady, M.D., Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
1.42M
+23.16%
Dr. Richard H. Douglas, Ph.D.
Dr. Richard H. Douglas, Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
125.00K
--
Mr. Martin J. Joyce
Mr. Martin J. Joyce
Independent Director
Independent Director
23.97K
--
Dr. Gary M. Phillips, M.D.
Dr. Gary M. Phillips, M.D.
Independent Director
Independent Director
14.81K
--
Dr. Neal S. Walker
Dr. Neal S. Walker
Independent Director
Independent Director
--
--
Dr. Stephen G. Machatha, Ph.D.
Dr. Stephen G. Machatha, Ph.D.
Chief Development Officer
Chief Development Officer
--
--
收入明细
暂无数据
暂无数据
业务
地区
暂无数据
股东统计
更新时间: 8月16日 周六
更新时间: 8月16日 周六
持股股东
股东类型
持股股东
持股股东
占比
Knoll Capital Management, LLC
9.14%
Perceptive Advisors LLC
6.76%
BlackRock Institutional Trust Company, N.A.
5.91%
The Vanguard Group, Inc.
5.85%
Ardsley Advisory Partners LP
3.42%
其他
68.92%
持股股东
持股股东
占比
Knoll Capital Management, LLC
9.14%
Perceptive Advisors LLC
6.76%
BlackRock Institutional Trust Company, N.A.
5.91%
The Vanguard Group, Inc.
5.85%
Ardsley Advisory Partners LP
3.42%
其他
68.92%
股东类型
持股股东
占比
Hedge Fund
19.07%
Investment Advisor
18.01%
Investment Advisor/Hedge Fund
11.10%
Private Equity
6.76%
Individual Investor
3.10%
Research Firm
2.16%
Family Office
0.25%
Pension Fund
0.18%
Bank and Trust
0.09%
其他
39.28%
机构持股
更新时间: 7月1日 周二
更新时间: 7月1日 周二
报告期
机构数
持股数
持股占比
持股变动
2025Q2
295
35.94M
60.00%
-7.70M
2025Q1
315
40.31M
67.37%
-4.94M
2024Q4
306
39.84M
66.72%
-5.42M
2024Q3
295
38.52M
64.82%
-5.60M
2024Q2
290
37.23M
62.65%
-8.21M
2024Q1
294
37.04M
62.88%
-7.70M
2023Q4
296
36.84M
62.63%
-6.52M
2023Q3
298
39.89M
68.07%
-12.41M
2023Q2
305
41.03M
70.05%
-8.66M
2023Q1
311
38.11M
64.83%
-12.64M
查看更多
股东持股明细
名称
持股数
占比
持股变动
变动比例
公告日期
Knoll Capital Management, LLC
5.48M
9.14%
--
--
Mar 31, 2025
Perceptive Advisors LLC
4.88M
8.14%
-4.40M
-47.44%
Apr 03, 2025
BlackRock Institutional Trust Company, N.A.
3.41M
5.7%
-50.91K
-1.47%
Mar 31, 2025
The Vanguard Group, Inc.
3.72M
6.21%
-38.77K
-1.03%
Mar 31, 2025
Ardsley Advisory Partners LP
1.75M
2.92%
+600.00K
+52.17%
Mar 31, 2025
AQR Capital Management, LLC
392.56K
0.66%
+321.99K
+456.32%
Mar 31, 2025
Brady (Todd C)
1.42M
2.38%
+267.69K
+23.16%
Apr 14, 2025
Kingdon Capital Management, L.L.C.
779.00K
1.3%
+779.00K
--
Mar 31, 2025
Geode Capital Management, L.L.C.
1.14M
1.9%
+18.27K
+1.63%
Mar 31, 2025
683 Capital Management LLC
476.00K
0.79%
+186.00K
+64.14%
Mar 31, 2025
查看更多
持股ETF
更新时间: 8月6日 周三
更新时间: 8月6日 周三
机构名称
占比
Invesco NASDAQ Future Gen 200 ETF
0.8%
iShares Micro-Cap ETF
0.05%
Vanguard US Momentum Factor ETF
0.04%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
0.03%
Global X Russell 2000 ETF
0.01%
Proshares Ultra Russell 2000
0.01%
iShares Russell 2000 ETF
0.01%
ProShares Hedge Replication ETF
0.01%
ProShares UltraPro Russell2000
0.01%
iShares Russell 2000 Growth ETF
0.01%
查看更多
Invesco NASDAQ Future Gen 200 ETF
占比0.8%
iShares Micro-Cap ETF
占比0.05%
Vanguard US Momentum Factor ETF
占比0.04%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
占比0.03%
Global X Russell 2000 ETF
占比0.01%
Proshares Ultra Russell 2000
占比0.01%
iShares Russell 2000 ETF
占比0.01%
ProShares Hedge Replication ETF
占比0.01%
ProShares UltraPro Russell2000
占比0.01%
iShares Russell 2000 Growth ETF
占比0.01%
分红派息
近5年累计派现
0.00
美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据
拆合股
公告日期
类型
比率
暂无数据
公告日期
类型
比率
暂无数据
